Inflammatory Demyelinating Diseases

Istvan Pirko, Charles R G Guttmann

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The spinal cord is commonly affected in inflammatory demyelinating diseases (IDD) of the central nervous system. In the most common IDD, multiple sclerosis (MS), the importance of spinal cord involvement is highlighted by the inclusion of characteristic cord lesions in its current diagnostic criteria. In neuromyelitis optica, longitudinally extensive spinal cord lesions over three or more segments are considered almost pathognomonic for the disease. In general, spinal cord lesion load shows a strong correlation with disability, and spinal cord-derived magnetic resonance imaging (MRI) measures are some of the strongest biomarkers of a disabling disease course. In progressive forms of MS, the clinical phenotype is consistent with a progressive myelopathy in most cases. These forms of MS, especially primary progressive MS, represent a major challenge for disease activity monitoring. Novel quantitative MRI metrics characterizing spinal cord involvement in MS are expected to find their way into routine clinical monitoring as they provide unique insight into tissue abnormalities, allowing for monitoring of disease progression and assessment of response to treatment. These techniques include magnetization transfer MRI, diffusion-weighted imaging, atrophy measurement techniques, T1 and T2 relaxometry, and magnetic resonance spectroscopy.

Original languageEnglish (US)
Title of host publicationQuantitative MRI of the Spinal Cord
PublisherElsevier Inc.
Pages22-38
Number of pages17
ISBN (Print)9780123969736
DOIs
StatePublished - Mar 2014

Fingerprint

Demyelinating Diseases
Spinal Cord
Multiple Sclerosis
Magnetic Resonance Imaging
Neuromyelitis Optica
Chronic Progressive Multiple Sclerosis
Diffusion Magnetic Resonance Imaging
Spinal Cord Diseases
Atrophy
Disease Progression
Magnetic Resonance Spectroscopy
Central Nervous System
Biomarkers
Phenotype

Keywords

  • Inflammatory myelopathy
  • Multiple sclerosis
  • Neuromyelitis optica
  • Paraneoplastic myelopathy
  • Transverse myelitis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Pirko, I., & Guttmann, C. R. G. (2014). Inflammatory Demyelinating Diseases. In Quantitative MRI of the Spinal Cord (pp. 22-38). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-396973-6.00002-2

Inflammatory Demyelinating Diseases. / Pirko, Istvan; Guttmann, Charles R G.

Quantitative MRI of the Spinal Cord. Elsevier Inc., 2014. p. 22-38.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pirko, I & Guttmann, CRG 2014, Inflammatory Demyelinating Diseases. in Quantitative MRI of the Spinal Cord. Elsevier Inc., pp. 22-38. https://doi.org/10.1016/B978-0-12-396973-6.00002-2
Pirko I, Guttmann CRG. Inflammatory Demyelinating Diseases. In Quantitative MRI of the Spinal Cord. Elsevier Inc. 2014. p. 22-38 https://doi.org/10.1016/B978-0-12-396973-6.00002-2
Pirko, Istvan ; Guttmann, Charles R G. / Inflammatory Demyelinating Diseases. Quantitative MRI of the Spinal Cord. Elsevier Inc., 2014. pp. 22-38
@inbook{544b893ebf224bd9b6ea5b3f4c6ea47a,
title = "Inflammatory Demyelinating Diseases",
abstract = "The spinal cord is commonly affected in inflammatory demyelinating diseases (IDD) of the central nervous system. In the most common IDD, multiple sclerosis (MS), the importance of spinal cord involvement is highlighted by the inclusion of characteristic cord lesions in its current diagnostic criteria. In neuromyelitis optica, longitudinally extensive spinal cord lesions over three or more segments are considered almost pathognomonic for the disease. In general, spinal cord lesion load shows a strong correlation with disability, and spinal cord-derived magnetic resonance imaging (MRI) measures are some of the strongest biomarkers of a disabling disease course. In progressive forms of MS, the clinical phenotype is consistent with a progressive myelopathy in most cases. These forms of MS, especially primary progressive MS, represent a major challenge for disease activity monitoring. Novel quantitative MRI metrics characterizing spinal cord involvement in MS are expected to find their way into routine clinical monitoring as they provide unique insight into tissue abnormalities, allowing for monitoring of disease progression and assessment of response to treatment. These techniques include magnetization transfer MRI, diffusion-weighted imaging, atrophy measurement techniques, T1 and T2 relaxometry, and magnetic resonance spectroscopy.",
keywords = "Inflammatory myelopathy, Multiple sclerosis, Neuromyelitis optica, Paraneoplastic myelopathy, Transverse myelitis",
author = "Istvan Pirko and Guttmann, {Charles R G}",
year = "2014",
month = "3",
doi = "10.1016/B978-0-12-396973-6.00002-2",
language = "English (US)",
isbn = "9780123969736",
pages = "22--38",
booktitle = "Quantitative MRI of the Spinal Cord",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Inflammatory Demyelinating Diseases

AU - Pirko, Istvan

AU - Guttmann, Charles R G

PY - 2014/3

Y1 - 2014/3

N2 - The spinal cord is commonly affected in inflammatory demyelinating diseases (IDD) of the central nervous system. In the most common IDD, multiple sclerosis (MS), the importance of spinal cord involvement is highlighted by the inclusion of characteristic cord lesions in its current diagnostic criteria. In neuromyelitis optica, longitudinally extensive spinal cord lesions over three or more segments are considered almost pathognomonic for the disease. In general, spinal cord lesion load shows a strong correlation with disability, and spinal cord-derived magnetic resonance imaging (MRI) measures are some of the strongest biomarkers of a disabling disease course. In progressive forms of MS, the clinical phenotype is consistent with a progressive myelopathy in most cases. These forms of MS, especially primary progressive MS, represent a major challenge for disease activity monitoring. Novel quantitative MRI metrics characterizing spinal cord involvement in MS are expected to find their way into routine clinical monitoring as they provide unique insight into tissue abnormalities, allowing for monitoring of disease progression and assessment of response to treatment. These techniques include magnetization transfer MRI, diffusion-weighted imaging, atrophy measurement techniques, T1 and T2 relaxometry, and magnetic resonance spectroscopy.

AB - The spinal cord is commonly affected in inflammatory demyelinating diseases (IDD) of the central nervous system. In the most common IDD, multiple sclerosis (MS), the importance of spinal cord involvement is highlighted by the inclusion of characteristic cord lesions in its current diagnostic criteria. In neuromyelitis optica, longitudinally extensive spinal cord lesions over three or more segments are considered almost pathognomonic for the disease. In general, spinal cord lesion load shows a strong correlation with disability, and spinal cord-derived magnetic resonance imaging (MRI) measures are some of the strongest biomarkers of a disabling disease course. In progressive forms of MS, the clinical phenotype is consistent with a progressive myelopathy in most cases. These forms of MS, especially primary progressive MS, represent a major challenge for disease activity monitoring. Novel quantitative MRI metrics characterizing spinal cord involvement in MS are expected to find their way into routine clinical monitoring as they provide unique insight into tissue abnormalities, allowing for monitoring of disease progression and assessment of response to treatment. These techniques include magnetization transfer MRI, diffusion-weighted imaging, atrophy measurement techniques, T1 and T2 relaxometry, and magnetic resonance spectroscopy.

KW - Inflammatory myelopathy

KW - Multiple sclerosis

KW - Neuromyelitis optica

KW - Paraneoplastic myelopathy

KW - Transverse myelitis

UR - http://www.scopus.com/inward/record.url?scp=84902648506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902648506&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-396973-6.00002-2

DO - 10.1016/B978-0-12-396973-6.00002-2

M3 - Chapter

AN - SCOPUS:84902648506

SN - 9780123969736

SP - 22

EP - 38

BT - Quantitative MRI of the Spinal Cord

PB - Elsevier Inc.

ER -